Ann Vasc Dis. 2019 Jun 25;12(2):260-279. doi: 10.3400/avd.ar.19-00030.
: This is an annual report indicating the number and early clinical results of annual vascular treatments performed by vascular surgeons in Japan in 2012, as analyzed by database management committee (DBC) members of the JSVS. : To survey the current status of vascular treatments performed by vascular surgeons in Japan, the DBC members of the JSVS analyzed the vascular treatment data provided by the NCD vascular surgery data analysis team, including the number of treatments and early clinical results such as operative and in-hospital mortality. : In total 95,979 vascular treatments were registered by 1,043 institutions in 2012. This database is composed of 7 fields including treatment of aneurysms, chronic arterial occlusive disease, acute arterial occlusive disease, vascular injury, complication of previous vascular reconstruction, venous diseases, and other vascular treatments. The number of vascular treatments in each field was 19,600, 13,141, 4,600, 1,623, 1,973, 30,725, and 24,332, respectively. In the field of aneurysm treatment, 15,745 cases with abdominal aortic aneurysms (AAA) including common iliac aneurysms were registered, and 47.6% were treated by stent graft. Among AAA cases, 1,704 (10.8%) cases were registered as ruptured AAA. The operative mortality of ruptured and non-ruptured AAA was 17.8%, and 0.8%, respectively. Regarding chronic arterial occlusive disease, open repair was performed in 7,859 cases, including 1,173 distal bypasses to the crural or pedal artery, whereas endovascular procedures were performed in 5,282 cases. Venous treatment including 30,088 cases with varicose vein treatments and 395 cases with lower limb deep venous thrombosis were registered. Regarding other vascular operations, 22,654 cases of vascular access operations and 1,390 amputation surgeries were included. The number of lower limb amputations was still increasing and the mortality rate of amputation surgery was also still high; both of these issues require improvement. : The number of vascular treatments increased since 2011, and the proportion of endovascular procedures increased in almost all fields of vascular diseases, especially endovascular aneurysm repair (EVAR) for aneurysms and endovenous laser ablation (EVLA) for varicose veins. (This is a translation of Jpn J Vasc Surg 2018; 27: 437-456.).
这是一份年度报告，展示了2012年日本血管外科医生进行的年度血管治疗的数量及早期临床结果，由日本血管外科学会（JSVS）数据库管理委员会（DBC）成员进行分析。为调查日本血管外科医生进行血管治疗的现状，JSVS的DBC成员分析了国家心血管疾病数据库（NCD）血管外科数据分析团队提供的血管治疗数据，包括治疗数量以及手术死亡率和住院死亡率等早期临床结果。2012年，共有1043家机构登记了95979例血管治疗。该数据库由7个领域组成，包括动脉瘤治疗、慢性动脉闭塞性疾病、急性动脉闭塞性疾病、血管损伤、既往血管重建并发症、静脉疾病以及其他血管治疗。每个领域的血管治疗数量分别为19600例、13141例、4600例、1623例、1973例、30725例和24332例。在动脉瘤治疗领域，登记了15745例包括髂总动脉瘤在内的腹主动脉瘤（AAA）病例，其中47.6%采用支架植入术治疗。在AAA病例中，1704例（10.8%）被登记为破裂性AAA。破裂性和非破裂性AAA的手术死亡率分别为17.8%和0.8%。对于慢性动脉闭塞性疾病，7859例进行了开放修复，其中1173例为远端小腿或足部动脉旁路移植术，而5282例进行了血管腔内手术。登记的静脉治疗包括30088例静脉曲张治疗和395例下肢深静脉血栓形成。关于其他血管手术，包括22654例血管通路手术和1390例截肢手术。下肢截肢数量仍在增加，截肢手术死亡率也仍然很高；这两个问题都需要改善。自2011年以来，血管治疗数量增加，血管腔内手术的比例在几乎所有血管疾病领域都有所增加，尤其是动脉瘤的血管腔内动脉瘤修复术（EVAR）和静脉曲张的静脉腔内激光消融术（EVLA）。（本文翻译自《日本血管外科学杂志》2018年；27卷：437 - 456页。）
